Surfacide® Announces Expansion Of UV-C Disinfection Technology Across All MedStar Health Hospital Locations

News provided by

Surfacide

Feb 16, 2023, 08:54 ET

WAUKESHA, Wis., Feb. 16, 2023 /PRNewswire/ -- Surfacide, the industry leader in UV-C disinfection technology, today announced that it is expanding the use of Surfacide's best-in-class Helios® low-level UV-C Disinfection System across all 10 hospitals in the MedStar Health system located in the Mid-Atlantic. With a renewed focus on disinfection within the operating room, the expansion allows MedStar Health to upgrade some of its existing Surfacide technology as well as deploy several new devices, making the Helios System even more accessible to patients, staff and guests.

Continue Reading
The Surfacide Helios system is the only patented, low-level UV-C disinfection solution to use a trio of light emitting 'robots' simultaneously, significantly reducing bacteria and virus on colonized surfaces
The Surfacide Helios system is the only patented, low-level UV-C disinfection solution to use a trio of light emitting 'robots' simultaneously, significantly reducing bacteria and virus on colonized surfaces
The Helios system provides UV-C energy to more exposed areas than single devices-boosting power, dosage and efficacy in a single cycle
The Helios system provides UV-C energy to more exposed areas than single devices-boosting power, dosage and efficacy in a single cycle

Since 2016, Surfacide has worked strategically with MedStar Health to successfully implement UV-C disinfection to help reduce the environment as a variable when it comes to infection prevention protocols. Surfacide is a critical component to the "5 Pillars of Safety in Healthcare", which is a CompassOne Healthcare philosophy.

The Surfacide Helios system is the only patented, low-level UV-C disinfection solution to use a trio of light emitting 'robots' simultaneously, significantly reducing bacteria and viruses on colonized surfaces. The Helios system provides UV-C energy to more exposed areas than single devices—boosting power, dosage and efficacy in a single cycle. The system can be easily moved and configured within different high-impact areas of a hospital such as patient rooms, patient bathrooms, ORs, outpatient/ambulatory surgery, burn units, labor & delivery, isolation rooms, etc.

"With the expansion and renewed focus on a robust UV-C disinfection program, MedStar Health continues to demonstrate leadership and commitment to their patients, staff and community," said Gunner Lyslo, Founder and CEO of Surfacide. "We are thankful to work with such a tremendous partner and are confident that these strategies will positively impact patient and staff satisfaction."

About Surfacide

Founded in 2010, Surfacide is a UV technology and infection solutions company producing scientifically proven, hospital-grade UV devices. Surfacide's award-winning Helios® System is the world's only patented, triple emitter 'robotic' UV light solution to rapidly reduce bioburden and pathogens. A trusted partner in infection prevention, Surfacide has been deployed in over 600 leading hospitals, nursing homes, dental offices, fire stations, prisons, police stations, commercial office spaces, hotels and public venues worldwide. Surfacide LLC is proud to be American-made and manufactured in Waukesha, WI. Visit the Surfacide website to learn more or contact one of our professional support specialists at (844)-390-3538.

Media Contacts:
Alexandra Skillman / Gina Doctor
Type A Marketing 
[email protected]
415-342-6425

SOURCE Surfacide

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED